Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical outcomes of non-diabetic COVID-19 patients with different blood glucose levels: a nationwide Turkish study (TurCoGlycemia).
Haymana C, Demirci I, Tasci I, Cakal E, Salman S, Ertugrul D, Ata N, Unluturk U, Dagdelen S, Atmaca A, Sahin M, Celik O, Demir T, Emral R, Sahin I, Caglayan M, Satman I, Sonmez A. Haymana C, et al. Among authors: demirci i. Endocrine. 2021 Aug;73(2):261-269. doi: 10.1007/s12020-021-02789-9. Epub 2021 Jun 22. Endocrine. 2021. PMID: 34156609 Free PMC article.
Impact of Obesity on the Metabolic Control of Type 2 Diabetes: Results of the Turkish Nationwide Survey of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD Obesity Study).
Sonmez A, Yumuk V, Haymana C, Demirci I, Barcin C, Kıyıcı S, Güldiken S, Örük G, Ozgen Saydam B, Baldane S, Kutlutürk F, Küçükler FK, Deyneli O, Çetinarslan B, Sabuncu T, Bayram F, Satman I; TEMD Study Group. Sonmez A, et al. Among authors: demirci i. Obes Facts. 2019;12(2):167-178. doi: 10.1159/000496624. Epub 2019 Mar 20. Obes Facts. 2019. PMID: 30893706 Free PMC article.
A Cross-Sectional Study of Overtreatment and Deintensification of Antidiabetic and Antihypertensive Medications in Diabetes Mellitus: The TEMD Overtreatment Study.
Sonmez A, Tasci I, Demirci I, Haymana C, Barcin C, Aydin H, Cetinkalp S, Ozturk FY, Gul K, Sabuncu T, Satman I, Bayram F; TEMD Study Group. Sonmez A, et al. Among authors: demirci i. Diabetes Ther. 2020 May;11(5):1045-1059. doi: 10.1007/s13300-020-00779-0. Epub 2020 Feb 22. Diabetes Ther. 2020. PMID: 32088879 Free PMC article.
Utilization of statins and LDL-cholesterol target attainment in Turkish patients with type 2 diabetes - a nationwide cross-sectional study (TEMD dyslipidemia study).
Bayram F, Sonmez A, Haymana C, Sabuncu T, Dizdar OS, Gurkan E, Carlioglu AK, Agbaht K, Ozdemir D, Demirci I, Barcin C, Salman S, Tetiker T, Balci MK, Kebapci N, Ersoy C, Yumuk V, Toth PP, Satman I; TEMD Study Group. Bayram F, et al. Among authors: demirci i. Lipids Health Dis. 2020 Nov 11;19(1):237. doi: 10.1186/s12944-020-01408-2. Lipids Health Dis. 2020. PMID: 33176832 Free PMC article.
Patterns and preferences of antidiabetic drug use in Turkish patients with type 2 diabetes - A nationwide cross-sectional study (TEMD treatment study).
Haymana C, Sonmez A, Demirci I, Fidan Yaylalı G, Nuhoglu I, Sancak S, Yilmaz M, Altuntas Y, Dinccag N, Sabuncu T, Bayram F, Satman I; TEMD Study Group. Haymana C, et al. Among authors: demirci i. Diabetes Res Clin Pract. 2021 Jan;171:108556. doi: 10.1016/j.diabres.2020.108556. Epub 2020 Nov 24. Diabetes Res Clin Pract. 2021. PMID: 33242516
Characteristics of patients with hypertension in a population with type 2 diabetes mellitus. Results from the Turkish Nationwide SurvEy of Glycemic and Other Metabolic Parameters of Patients with Diabetes Mellitus (TEMD Hypertension Study).
Sabuncu T, Sonmez A, Eren MA, Sahin I, Çorapçioğlu D, Üçler R, Akin Ş, Haymana C, Demirci İ, Atmaca A, Ersöz HÖ, Satman I, Bayram F; TEMD Study Group. Sabuncu T, et al. Among authors: demirci i. Prim Care Diabetes. 2021 Apr;15(2):332-339. doi: 10.1016/j.pcd.2020.11.001. Epub 2020 Dec 1. Prim Care Diabetes. 2021. PMID: 33277201
Clinical characteristics and outcomes of COVID-19 in patients with type 2 diabetes in Turkey: A nationwide study (TurCoviDia).
Sonmez A, Demirci I, Haymana C, Tasci I, Dagdelen S, Salman S, Ata N, Sahin I, Emral R, Cakal E, Atmaca A, Sahin M, Celik O, Demir T, Ertugrul D, Unluturk U, Caglayan M, Satman I. Sonmez A, et al. Among authors: demirci i. J Diabetes. 2021 Jul;13(7):585-595. doi: 10.1111/1753-0407.13171. Epub 2021 Mar 24. J Diabetes. 2021. PMID: 33655669 Free PMC article.
Unexpectedly lower mortality rates in COVID-19 patients with and without type 2 diabetes in Istanbul.
Satman I, Demirci I, Haymana C, Tasci I, Salman S, Ata N, Dagdelen S, Sahin I, Emral R, Cakal E, Atmaca A, Sahin M, Celik O, Demir T, Ertugrul D, Unluturk U, Arga KY, Caglayan M, Sonmez A. Satman I, et al. Among authors: demirci i. Diabetes Res Clin Pract. 2021 Apr;174:108753. doi: 10.1016/j.diabres.2021.108753. Epub 2021 Mar 17. Diabetes Res Clin Pract. 2021. PMID: 33741352 Free PMC article.
43 results